5eqg: Difference between revisions

No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:


==MFS transporter in complex with inhibitor (2~{S})-3-(4-fluorophenyl)-2-[2-(3-hydroxyphenyl)ethanoylamino]-~{N}-[(1~{S})-1-phenylethyl]propanamide==
==Human GLUT1 in complex with inhibitor (2~{S})-3-(4-fluorophenyl)-2-[2-(3-hydroxyphenyl)ethanoylamino]-~{N}-[(1~{S})-1-phenylethyl]propanamide==
<StructureSection load='5eqg' size='340' side='right' caption='[[5eqg]], [[Resolution|resolution]] 2.90&Aring;' scene=''>
<StructureSection load='5eqg' size='340' side='right'caption='[[5eqg]], [[Resolution|resolution]] 2.90&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5eqg]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EQG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5EQG FirstGlance]. <br>
<table><tr><td colspan='2'>[[5eqg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EQG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5EQG FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5RE:(2~{S})-3-(4-FLUOROPHENYL)-2-[2-(3-HYDROXYPHENYL)ETHANOYLAMINO]-~{N}-[(1~{S})-1-PHENYLETHYL]PROPANAMIDE'>5RE</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.9&#8491;</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4pyp|4pyp]], [[5eqh|5eqh]], [[5eqi|5eqi]]</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5RE:(2~{S})-3-(4-FLUOROPHENYL)-2-[2-(3-HYDROXYPHENYL)ETHANOYLAMINO]-~{N}-[(1~{S})-1-PHENYLETHYL]PROPANAMIDE'>5RE</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5eqg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5eqg OCA], [http://pdbe.org/5eqg PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5eqg RCSB], [http://www.ebi.ac.uk/pdbsum/5eqg PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5eqg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5eqg OCA], [https://pdbe.org/5eqg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5eqg RCSB], [https://www.ebi.ac.uk/pdbsum/5eqg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5eqg ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/GTR1_HUMAN GTR1_HUMAN]] Hereditary cryohydrocytosis with reduced stomatin;Paroxysmal exertion-induced dyskinesia;Encephalopathy due to GLUT1 deficiency;Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity;Childhood absence epilepsy;Epilepsy with myoclonic-astatic seizures. The disease is caused by mutations affecting the gene represented in this entry.  The disease is caused by mutations affecting the gene represented in this entry.  The disease is caused by mutations affecting the gene represented in this entry.  The disease is caused by mutations affecting the gene represented in this entry.  
[https://www.uniprot.org/uniprot/GTR1_HUMAN GTR1_HUMAN] Hereditary cryohydrocytosis with reduced stomatin;Paroxysmal exertion-induced dyskinesia;Encephalopathy due to GLUT1 deficiency;Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity;Childhood absence epilepsy;Epilepsy with myoclonic-astatic seizures. The disease is caused by mutations affecting the gene represented in this entry.  The disease is caused by mutations affecting the gene represented in this entry.  The disease is caused by mutations affecting the gene represented in this entry.  The disease is caused by mutations affecting the gene represented in this entry.
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/GTR1_HUMAN GTR1_HUMAN]] Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.  
[https://www.uniprot.org/uniprot/GTR1_HUMAN GTR1_HUMAN] Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 25: Line 25:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Bringmann, P]]
[[Category: Homo sapiens]]
[[Category: Caboni, L]]
[[Category: Large Structures]]
[[Category: Finer-Moore, J]]
[[Category: Bringmann P]]
[[Category: Heisler, I]]
[[Category: Caboni L]]
[[Category: Hillig, R]]
[[Category: Finer-Moore J]]
[[Category: Kapoor, K]]
[[Category: Heisler I]]
[[Category: Muller, T]]
[[Category: Hillig R]]
[[Category: Pedersen, B P]]
[[Category: Kapoor K]]
[[Category: Siebeneicher, H]]
[[Category: Muller T]]
[[Category: Stroud, R M]]
[[Category: Pedersen BP]]
[[Category: Waight, A B]]
[[Category: Siebeneicher H]]
[[Category: Glucose transporter]]
[[Category: Stroud RM]]
[[Category: Mfs transporter]]
[[Category: Waight AB]]
[[Category: Transport protein-inhibitor complex]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA